At a glance
- Originator Aventis
- Class Anti-ischaemics; Antiarrhythmics; Antihypertensives
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Hypertension; Ischaemic heart disorders
Most Recent Events
- 20 Mar 1997 Dicontinued for Hypertension
- 20 Mar 1997 Discontinued for Ischaemic Heart Disorders
- 20 Mar 1997 Discontinued-preclinical for Arrhythmias